Data from Codiak s exoASO™-STAT6 Preclinical Development Program for the Treatment of Primary and Metastatic Hepatic Cancers Published in Science Advances forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development
April 15, 2021 GMT
SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Apr 15, 2021
CERo Therapeutics, Inc., a biopharmaceutical company pioneering the development of novel autologous engineered immune cellular therapies, today announced the expansion of the company’s leadership team with the addition of Remus Vezan, M.D., Ph.D. as Chief Medical Officer (CMO) and John Rossi, M. Sci. as Senior Vice President and Head of Translational Medicine. Dr. Vezan and Mr. Rossi have been instrumental in the successful development of marketed CAR T-cell therapies in their prior roles. At CERo, they will lead the company’s clinical development efforts to rapidly advance its T cell engineering platform and next-generation cell therapy products. CERo’s novel approach combines elements of both innate and adaptive immune res